Previous Close | 57.91 |
1-Year Change | 3.34% |
6-Months Change | -2.11% |
3-Months Change | 1.05% |
Moving Avg (50d) | 56.615 |
Moving Avg (200d) | 60.308 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.09B |
Beta (3-Years) | 0.81 |
Revenue Growth (ttm) | 58.75% |
Net Profit Margin (ttm) | 2.98% |
Return On Assets (ttm) | 1.5% |
EPS (ttm) | 0.51 |
PE Ratio (ttm) | 113.55 |
Dividend Yield | 0.16% |
Asset Description: | ANI Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
56.752 | 55.014 | 53.856 | 52.119 | 49.223 | 46.328 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.